help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2003-0162
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wan, Y.
Right arrow Articles by Waters, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wan, Y.
Right arrow Articles by Waters, M. J.
Molecular Endocrinology 17 (11): 2240-2250
Copyright © 2003 by The Endocrine Society

Epitope Map for a Growth Hormone Receptor Agonist Monoclonal Antibody, MAb 263

Yu Wan, Yuan Zhi Zheng, Jonathan M. Harris, Richard Brown and Michael J. Waters

School of Biomedical Sciences and Institute for Molecular Bioscience (Y.W., R.B., M.J.W.) and School of Molecular & Microbial Science (Y.Z.Z.), University of Queensland, Brisbane, Queensland 4072, Australia; and School of Life Science (J.M.H.), Queensland University of Technology, Brisbane, 4000 Queensland, Australia

Address all correspondence and requests for reprints to: Professor M. J. Waters, E-mail: m.waters{at}mailbox.uq.edu.au.

Monoclonal antibody (MAb) 263 is a widely used monoclonal antibody that recognizes the extracellular domain (ECD) of the GH receptor. It has been shown to act as a GH agonist both in vitro and in vivo, and we report here that it must be divalent to exert its effect on the full-length receptor. To understand the mechanism of its agonist action, we have determined the precise epitope for this antibody using a novel random PCR mutagenesis approach together with expression screening in yeast. A library of 5200 clones of rabbit GH receptor ECD mutants were screened both with MAb 263 and with an anticarboxy-tag antibody to verify complete ECD expression. Sequencing for clones that expressed complete ECD but were not MAb 263 positive identified 20 epitope residues distributed in a discontinuous manner throughout the ECD. The major part of the epitope, as revealed after mapping onto the crystal structure model of the ECD molecule, was located on the side and upper portion of domain 1, particularly within the D–E strand disulfide loop 79–96. Molecular dynamics docking of an antibody of the same isotype as MAb 263 was used to dock the bivalent antibody to the 1528-Å2 epitope and to visualize the likely consequences of MAb binding. The minimized model enables the antibody to grasp two receptors in a pincer-like movement from opposite sides, facilitating alignment of the receptor dimerization domains in a manner similar to, but not identical with, GH.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. Frystyk, C. M. Andreasen, and S. Fisker
Determination of Free Growth Hormone
J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3008 - 3014.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. L. Conway-Campbell, J. W. Wooh, A. J. Brooks, D. Gordon, R. J. Brown, A. M. Lichanska, H. S. Chin, C. L. Barton, G. M. Boyle, P. G. Parsons, et al.
Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis
PNAS, August 14, 2007; 104(33): 13331 - 13336.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. E. Bowles, I. Wilkinson, R. A. G. Smith, A. J. G. Moir, H. Montgomery, and R. J. M. Ross
Membrane Reinsertion of a Myristoyl-Peptidyl Anchored Extracellular Domain Growth Hormone Receptor
Endocrinology, February 1, 2007; 148(2): 824 - 830.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M J Waters, H N Hoang, D P Fairlie, R A Pelekanos, and R J Brown
New insights into growth hormone action
J. Mol. Endocrinol., February 1, 2006; 36(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Landsman and D. J. Waxman
Role of the Cytokine-induced SH2 Domain-containing Protein CIS in Growth Hormone Receptor Internalization
J. Biol. Chem., November 11, 2005; 280(45): 37471 - 37480.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Jiang, X. Wang, K. He, X. Li, C. Chen, P. P. Sayeski, M. J. Waters, and S. J. Frank
A Conformationally Sensitive GHR [Growth Hormone (GH) Receptor] Antibody: Impact on GH Signaling and GHR Proteolysis
Mol. Endocrinol., December 1, 2004; 18(12): 2981 - 2996.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wan, A. McDevitt, B. Shen, M. L. Smythe, and M. J. Waters
Increased Site 1 Affinity Improves Biopotency of Porcine Growth Hormone: EVIDENCE AGAINST DIFFUSION DEPENDENT RECEPTOR DIMERIZATION
J. Biol. Chem., October 22, 2004; 279(43): 44775 - 44784.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society